Kangni Lin

Kangni Lin

Auto-generated profile, based on publicly available information

Kangni Lin

Department of Hematology Fujian Institute of Hematology Fujian Provincial Key Laboratory of Hematology Fujian Medical University Union Hospital Fuzhou Fujian P. R. China

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 November 2023 in Clinical Transplantation
Verified
Journal Article
Closed access
JRJinhua Ren
Jinhua Ren
KLKangni Lin
Kangni Lin
JXJingjing Xu
Jingjing Xu
QLQuanyi Lu
Quanyi Lu
YLYiming Luo
Yiming Luo
TYTing Yang
Ting Yang

1 January 2023 in Annals of Translational Medicine
Verified
Journal Article
Open access
PDF file
SLShaofeng Lin
Shaofeng Lin
JLJingping Lin
Jingping Lin
JWJinsen Weng
Jinsen Weng
WSWeikun Su
Weikun Su
GWGuibin Weng
Guibin Weng
KLKangni Lin
Kangni Lin
Original Article Combination of neutrophil-to-lymphocyte ratio and albumin concentration to predict the prognosis of esophageal squamous cell cancer patients undergoing esophagectomy Shaofeng Lin, Jingping Lin, Jinsen Weng, Weikun Su, Guibin Weng, Yuanmei Chen, Noriyuki Hirahara, Yang Won Min, Xiaohui Chen, Kunshou Zhu, Kangni Lin

21 April 2026 in SSRN Electronic Journal
Verified
Preprint
Open access
YSYongshi Shen
Yongshi Shen
JWJinsen Weng
Jinsen Weng
KLKangni Lin
Kangni Lin
PZPeng Zheng
Peng Zheng
WZWei Zhang
Wei Zhang
YYYong Ye
Yong Ye
Background: Noncardiac surgical patients requiring postoperative vasopressors are biologically heterogeneous, yet current guidelines provide no validated bedside tool to stratify mean arterial pressure (MAP) targets by haemodynamic subtype.Methods: In this three-database retrospective cohort study, we analysed adult noncardiac postoperative patients with vasopressor-dependent hypotension (PVDH) in SICdb (discovery; n=2,700), MIMIC-IV (external validation; n=2,821), and eICU-CRD (external validation; n=1,478). Group-based trajectory modelling (GBTM) was fitted de novo in each database using simultaneous 24-hour trajectories of MAP, noradrenaline-equivalent (NEE) dose, and urine output. An eight-feature parsimonious XGBoost model trained on SICdb was externally validated to detect the highest-risk phenotype within six hours of vasopressor initiation.Findings: GBTM reproducibly identified three phenotypes: P0 (Perfusion-Preserved Recovery, 33–53%), P1 (Vasopressor-Dependent Stable, 33–56%), and P2 (Perfusion-Impaired Shock, 12–22%). P2 was characterised by escalating vasopressors, sustained hypotension, progressive oliguria, and hospital mortality 34·4–43·8%. Adjusted odds ratios for hospital mortality (P2 versus P0+P1) were 3·80 (95% CI 2·82–5·11), 3·43 (2·68–4·40), and 2·78 (2·01–3·85) in SICdb, MIMIC-IV, and eICU-CRD respectively (all p<0·0001); E-values 5·01–7·06. The eight-feature model achieved AUC 0·949 (SICdb cross-validation), 0·934 (95% CI 0·921–0·945) in MIMIC-IV, and 0·861 (0·838–0·883) in eICU-CRD. The vasopressor efficiency index (MAP/NEE) at initiation was 2·6- to 4·3-fold lower in P2 than P0 and declined progressively over 24 hours in MIMIC-IV P2 whereas P0 and P1 recovered—consistent with haemodynamic incoherence.Interpretation: Vasopressor-treated noncardiac postoperative patients comprise three reproducible haemodynamic phenotypes. P2, detectable within six hours using eight routine variables, carries three- to four-fold excess mortality linked to progressive vasopressor efficiency decline. This score provides the first externally validated bedside tool (pending prospective validation) addressing the individualised MAP target gap identified by guidelines, and defines enrichment criteria for precision resuscitation trials.